tirzepatide
ProductHeard on podcasts recently
Tirzepatide is a prescription medication that activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is used under brand names including Mounjaro for type 2 diabetes and Zepbound for chronic weight management in eligible adults.
Rank this week
—
Not in this week’s list
Share of the conversation
—
Reach this week
—
Tone this week
—
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of tirzepatide per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 21 | 0.03‰ | 1 |
| Aug 25 | 0.03‰ | 1 |
| Sep 1 | 0.01‰ | 1 |
| Sep 3 | 0.04‰ | 3 |
| Sep 17 | 0.01‰ | 1 |
| Oct 10 | 0.01‰ | 1 |
| Oct 23 | 0.01‰ | 1 |
| Oct 29 | 0.02‰ | 1 |
| Nov 4 | 0.02‰ | 1 |
| Nov 5 | 0.02‰ | 1 |
| Nov 9 | 0.02‰ | 1 |
| Nov 12 | 0.02‰ | 1 |
Who is saying what about tirzepatide
Verified quotes from the last 90 days: who made the most claims, and which way they leaned.
- Tiwa Adebayo1 claim on 1 show
“Petrelatide, had trial results which haven't been super positive, showing high discontinuation rates”
Stock Movers · Oct 8 ↗
Discussed alongside
Names that come up in the same conversations as tirzepatide.
Embed this
Paste this on your site to show tirzepatide's current trend:
<iframe src="https://podlume.ai/embed/e/tirzepatide" width="360" height="220" style="border:0" loading="lazy" title="tirzepatide on PodLume Trends"></iframe>